Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
S. Nag(Sahyadri Hospital), A. Oaknin(Vall d'Hebron Hospital Universitari), Siriwan Tangjitgamol(Navamindradhiraj University), Ashish Pathak(South Essex Partnership University Foundation NHS Trust), Wen-Yee Chay(National Cancer Centre Singapore), G. Pentheroudakis(European Society for Medical Oncology), Florencia G. Que(Mayo Clinic), Takayuki Yoshino(University of Tsukuba), Valerie Heong(Walter and Eliza Hall Institute of Medical Research), Widyorini Lestari Hutami Hanafi(Dharmais Cancer Hospital), M R Ngu(Sarawak General Hospital), Touch Ativitavas, Jian‐Mei Li(Army Medical University), Mayu Yunokawa(Japanese Foundation For Cancer Research), Resti Mulya Sari(Dharmais Cancer Hospital), G M Kim(Yonsei University), Andrés Cervantes(INCLIVA Health Research Institute), H-C Lai(Taipei Medical University-Shuang Ho Hospital), S.F. Ang(Penang Adventist Hospital), J. Tolentino(University of Asia and the Pacific), Elizabeth Smyth(Cambridge University Hospitals NHS Foundation Trust), Kenichi Harano(National Cancer Center Hospital East), Isabelle Ray Coquard(Centre Léon Bérard), Maheboob Basade(Breach Candy Hospital)
Cited by 3
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k